In this interview with Rob Royea, the CEO of Cyrcadia Health (formerly known as First Warning Systems) we are introduced to the company’s novel approach to breast cancer screening. By incorporating flexible electronics into a bra, the company has developed the ability to detect thermal fingerprints that are highly correlated with breast cancer. Unlike prior attempts to use thermography, Cyrcadia’s technology detects abnormal circadian changes in heat production characteristic of breast cancer and then runs them against proprietary predictive analytic algorithms to make a determination of possible cancer. An associated mobile app allows social sharing so family members at risk can be encouraged to do monthly screenings with the device.
Scroll to comments to see company updates.
(This video is under BY-ND creative commons.)